Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes

Inclusion Criteria: 1. Participant must provide written informed consent prior to any clinical study-related procedure. 2. Participant is at least 18 years (or the minimum age required by local law to consent for participation in a clinical investigation) or older at the time of enrollment. 3. Participant has a permanent Medtronic Intellis™ neurostimulation system implanted or is planning to be implanted with a Medtronic Intellis™ or Vanta™ neurostimulation system. 4. Participant has access to an iPhone or Android capable device and/or computer with regular internet access for the purposes of electronically completing web-based participant self-reported questionnaires via SMS text or email. Exclusion Criteria: 1. Participant is unable to provide written informed consent or to comply with study-related requirements, procedures, and visits. 2. Participant is a profound responder for all pain areas to existing neurostimulation therapy (≥80% reported relief). 3. Participant is enrolled, or intends to participate, in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug, or additional testing beyond standard of care procedures) which could confound the results of this trial as determined by the investigator. 4. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the participant's ability to participate in the clinical investigation or to comply with follow-up requirements. 5. Participant is pregnant or nursing.